HIGHLIGHTS
- who: A. Asokan from the (UNIVERSITY) have published the article: Debridement, antibiotics, and implant retention in non-oncological femoral megaprosthesis infections: minimum 5u2009year follow-up, in the Journal: (JOURNAL)
- what: The study reports a 64.3% success rate of DAIR used in non-oncological femoral megaprostheses with a minimum of five-year follow-up. In contrast, the study reports a 64.3% success rate, with most patients requiring only one debridement, at a significantly longer follow-up time (mean 93 months vs 39.6 months). In the study , empirical antibiotics were started only once intraoperative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.